GEHC logo GE HealthCare Technologies +
GE HealthCare Technologies
+

GE HealthCare Technologies Competitors & Alternatives

GE HealthCare Technologies competitors and alternatives

Jump
Company
Company
Ticker
GEHC
Headquarter
Chicago ,IL
US
CEO
Peter J. Arduini
Industry
Medical - Healthcare Information Services
Stock Price
Stock Price
Market Cap
Market Cap
$27.14 B
Employees
Years
  • 2023
  • 2024
  • 2025
Employees
  • 51.00 K
  • 53.00 K
  • 0
Y/Y
2%
3.92%
100%

Income Statement

Revenue
Years
  • 2023
  • 2024
  • 2025
Revenue
  • $19.55 B
  • $19.67 B
  • $20.63 B
Y/Y
6.6%
0.61%
4.84%
Revenue by Products / Services
Years
  • 2025
Revenue by Geography
Years
  • 2025
Research and Development
Years
  • 2023
  • 2024
  • 2025
Research and Development
  • $1.21 B
  • $1.31 B
  • $1.26 B
Y/Y
17.45%
8.8%
3.89%
Operating Income
Years
  • 2023
  • 2024
  • 2025
Operating Income
  • $2.44 B
  • $2.63 B
  • $2.76 B
Y/Y
3.45%
7.8%
5.22%
Tax Rate (%)
Years
  • 2023
  • 2024
  • 2025
Tax Rate (%)
  • 31.47%
  • 20.57%
  • 22.18%
Y/Y
40.41%
34.62%
7.82%
Net Income
Years
  • 2023
  • 2024
  • 2025
Net Income
  • $1.57 B
  • $1.99 B
  • $2.08 B
Y/Y
18.16%
27.1%
4.57%
Revenue Per Employee
Years
  • 2023
  • 2024
  • 2025
Revenue Per Employee
  • $383.37 K
  • $371.17 K
  • -
Y/Y
4.51%
3.18%
100%
Net Income Per Employee
Years
  • 2023
  • 2024
  • 2025
Net Income Per Employee
  • $30.75 K
  • $37.60 K
  • -
Y/Y
19.77%
22.31%
100%

Assets & Liabilities | Cash Flow

Total Assets
Years
  • 2023
  • 2024
  • 2025
Total Assets
  • $32.45 B
  • $33.09 B
  • $36.91 B
Y/Y
17.85%
1.96%
11.54%
Total Liabilities
Years
  • 2023
  • 2024
  • 2025
Total Liabilities
  • $25.14 B
  • $24.44 B
  • $26.31 B
Y/Y
40.1%
2.82%
7.66%
Capital Expenditures (Capex)
Years
  • 2023
  • 2024
  • 2025
Capital Expenditures (Capex)
  • -$387.00 M
  • -$401.00 M
  • -$482.00 M
Y/Y
24.84%
3.62%
20.2%

Profitability

Operating Income Margin (%)
Years
  • 2023
  • 2024
  • 2025
Operating Income Margin (%)
  • 12.45%
  • 13.34%
  • 13.39%
Y/Y
9.43%
7.15%
0.36%
Net Income Margin (%)
Years
  • 2023
  • 2024
  • 2025
Net Income Margin (%)
  • 8.02%
  • 10.13%
  • 10.10%
Y/Y
23.23%
26.33%
0.27%
EBITDA
Years
  • 2023
  • 2024
  • 2025
EBITDA
  • $3.51 B
  • $3.67 B
  • $3.79 B
Y/Y
11%
4.36%
3.25%
Free Cash Flow (FCF)
Years
  • 2023
  • 2024
  • 2025
Free Cash Flow (FCF)
  • $1.71 B
  • $1.55 B
  • $1.51 B
Y/Y
4.94%
9.57%
2.84%

Ratios

Return on Equity (ROE)
Years
  • 2023
  • 2024
  • 2025
Return on Equity (ROE)
  • 21.98%
  • 23.59%
  • 16.19%
Y/Y
7.35%
7.33%
31.4%
Return on Assets (ROA)
Years
  • 2023
  • 2024
  • 2025
Return on Assets (ROA)
  • 4.83%
  • 6.02%
  • 4.55%
Y/Y
30.56%
24.67%
24.42%
Debt to Equity
Years
  • 2023
  • 2024
  • 2025
Debt to Equity
  • 138.27%
  • 111.00%
  • 96.38%
Y/Y
49.83%
19.73%
13.17%

Valuation

Enterprise Value
Years
  • 2023
  • 2024
  • 2025
Enterprise value
  • $42.54 B
  • $42.14 B
  • $33.44 B
Y/Y
26.27%
0.95%
20.64%
Enterprise value to Revenue
Years
  • 2023
  • 2024
  • 2025
Enterprise value to Revenue
  • 2.18
  • 2.14
  • 1.71
Y/Y
18.45%
1.55%
20.35%
Enterprise value to EBITDA
Years
  • 2023
  • 2024
  • 2025
Enterprise value to EBITDA
  • 12.11
  • 11.49
  • 9.34
Y/Y
13.76%
5.08%
18.73%

Related company

Submit feedback to Bullfincher